Published by Michele Maatouk on 17th June 2024
(Sharecast News) - Hikma Pharmaceuticals said on Monday that it has agreed to buy parts of Xellia Pharmaceuticals, a Copenhagen-based specialty company focusing on providing anti-infective treatments and other critical care therapies, for up to $185m.
URL: http://www.digitallook.com/dl/news/story/34365231/...